比亞迪AH股齊漲 騰勢D9預售火爆
格隆匯5月17日丨比亞迪AH股齊漲,目前均漲近3%。消息面上,比亞迪高端品牌騰勢日前正式發佈,同時,豪華全能MPV騰勢D9開啟預售,提供6款車型,其中DM-i超級混動版4款,預售價為33.5-44.5萬元,純電版2款,預售價為39-46萬元。據騰勢汽車官微消息,騰勢D9預售30分鐘,訂單就已超過3000台,十分搶手。在昨晚的騰勢品牌發佈會上,比亞迪董事長兼總裁王傳福表示,在比亞迪汽車的業務板塊中,騰勢品牌將承接兼容比亞迪王朝系列、海洋系列向上銜接尚未發佈的高端品牌。未來比亞迪將負責騰勢品牌的戰略規劃,特別是在技術研發、產品規劃等方面為騰勢提供全方位的強有力支持。同時,奔馳也將繼續支持騰勢的事業發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.